172 related articles for article (PubMed ID: 34733662)
1. MiRNA-124 regulates the sensitivity of renal cancer cells to cisplatin-induced necroptosis by targeting the CAPN4-CNOT3 axis.
Mao Q; Zhuang Q; Shen J; Chen Z; Xue D; Ding T; He X
Transl Androl Urol; 2021 Sep; 10(9):3669-3683. PubMed ID: 34733662
[TBL] [Abstract][Full Text] [Related]
2. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
[TBL] [Abstract][Full Text] [Related]
3. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
[TBL] [Abstract][Full Text] [Related]
4. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
5. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway.
Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579
[TBL] [Abstract][Full Text] [Related]
6. miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4.
Hu H; Wang G; Li C
Onco Targets Ther; 2017; 10():2711-2720. PubMed ID: 28579809
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Capn4 by microRNA-1271 impedes the proliferation and invasion of colorectal cancer cells.
Li J; Xu J; Yan X; Jin K; Li W; Zhang R
Biomed Pharmacother; 2018 Mar; 99():162-168. PubMed ID: 29331762
[TBL] [Abstract][Full Text] [Related]
8. miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A.
Huang X; Jia Y; Shi H; Fan H; Sun L; Zhang H; Wang Y; Chen J; Han J; Wang M; Du J; Zhang J
Asian Biomed (Res Rev News); 2023 Jun; 17(3):124-135. PubMed ID: 37818158
[TBL] [Abstract][Full Text] [Related]
9. MiR-124 protects against cognitive dysfunction induced by sevoflurane anesthesia in vivo and in vitro through targeting calpain small subunit 1 via NF-κB signaling pathway.
Zhao Z; Ma L; Li Y; Zhang Q; Wang Y; Tai Y; Wang Q
Adv Clin Exp Med; 2021 Jul; 30(7):701-709. PubMed ID: 34118141
[TBL] [Abstract][Full Text] [Related]
10. CNOT3 contributes to cisplatin resistance in lung cancer through inhibiting RIPK3 expression.
Jing L; Zhai ME; Cui J; Fan XY; Cheng YY; Jiang JL; Chen ZN
Apoptosis; 2019 Aug; 24(7-8):673-685. PubMed ID: 31177396
[TBL] [Abstract][Full Text] [Related]
11. miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4.
Cai JJ; Qi ZX; Chen LC; Yao Y; Gong Y; Mao Y
Oncol Rep; 2016 Jan; 35(1):284-90. PubMed ID: 26530859
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA ABCB10 promotes cell proliferation and invasion, but inhibits apoptosis via regulating the microRNA‑1271‑mediated Capn4/Wnt/β‑catenin signaling pathway in epithelial ovarian cancer.
Lin X; Chen Y; Ye X; Xia X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760208
[TBL] [Abstract][Full Text] [Related]
13. Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer.
Jing L; Zhai ME; Qian MR; Li YM; Han MW; Wang K; Huang W; Nan G; Jiang JL
Cell Death Discov; 2023 Nov; 9(1):406. PubMed ID: 37919290
[TBL] [Abstract][Full Text] [Related]
14. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
[TBL] [Abstract][Full Text] [Related]
15. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of Long Non-Coding RNA
Zhan Y; Abuduwaili K; Wang X; Shen Y; Nuerlan S; Liu C
Cancer Manag Res; 2020; 12():7725-7737. PubMed ID: 32943921
[TBL] [Abstract][Full Text] [Related]
17. miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy.
Zhou Y; Wang C; Ding J; Chen Y; Sun Y; Cheng Z
Cancer Cell Int; 2022 Jan; 22(1):15. PubMed ID: 35012539
[TBL] [Abstract][Full Text] [Related]
18. MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1.
Zhang Y; Xu W; Ni P; Li A; Zhou J; Xu S
Int J Biol Sci; 2016; 12(12):1437-1447. PubMed ID: 27994509
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
Wang D; Zhu X; Siqin B; Ren C; Yi F
Toxicol Appl Pharmacol; 2022 Jul; 447():116067. PubMed ID: 35597301
[TBL] [Abstract][Full Text] [Related]
20. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
Shao N; Song L; Sun X
Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
